Synta Pharmaceuticals (SNTA +3.6%) trades up after saying it's entered into stock purchase agreements with members of its Board and various institutional investors to sell 7M shares of its common stock in an issuer directed, registered direct offering. Shares were priced at $8.60, yesterday's closing bid price. Gross proceeds from the sale were approximately $60M.
Synta Pharmaceuticals (SNTA +3.6%) trades up after saying it's entered into stock purchase...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs